Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
2.
Goh S (2015) Title of news article on zoledronic acid and bone density was misleading. BMJ 350:h2337CrossRefPubMed
3.
Grey A, Reid IR (2006) Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Ther Clin Risk Manag 2:77–86PubMedPubMedCentral
4.
Prieto-Alhambra D, Nogues X, Javaid MK, Wyman A, Arden NK, Azagra R, Cooper C, Adachi JD, Boonen S, Chapurlat RD, Compston JE, Gehlbach SH, Greenspan SL, Hooven FH, Netelenbos JC, Pfeilschifter J, Rossini M, Sambrook PN, Silverman S, Siris ES, Watts NB, Díez-Pérez A (2013) An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW). Ann Rheum Dis 72:911–917CrossRefPubMed
5.
Silverman SL, Ott SM, Dell RM (2010) Bisphosphonates and atypical femoral fractures. N Engl J Med 363:1083 author reply 1084–1085
6.
X. Li, J.-X. Ye, M.-H. Xu, M.-D. Zhao, F.-L. Yuan, (2017) Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway. Osteoporosis International 28 (7):2221–2231
Metadata
Title
Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture
Authors
Q.-Y. Wu
F.-L. Yuan
B. Wang
X. Li
Publication date
01-09-2018
Publisher
Springer London
Published in
Osteoporosis International / Issue 9/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4614-6

Other articles of this Issue 9/2018

Osteoporosis International 9/2018 Go to the issue

Original Article

Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam

Short Communication

Abnormal bone turnover in individuals with low serum alkaline phosphatase

Letter to the Editor

Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia

Review

Dietary fat, saturated fatty acid, and monounsaturated fatty acid intakes and risk of bone fracture: a systematic review and meta-analysis of observational studies

Correction

Correction to: Compressive loading of the murine tibia reveals site-specific micro-scale differences in adaptation and maturation rates of bone

Review

Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature